Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Overview of attention for article published in New England Journal of Medicine, March 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 215 news outlets
blogs: 25 blogs
policy: 4 policy sources
twitter: 758 X users
patent: 26 patents
facebook: 48 Facebook pages
wikipedia: 5 Wikipedia pages

googleplus: 8 Google+ users
reddit: 35 Redditors
f1000: 1 research highlight platform
q&a: 1 Q&A thread
video: 9 YouTube creators
guideline: 40 clinical guideline sources
podcasts: 14 podcasts

Readers on

mendeley: 3119 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 28 posts from 25 blogs.

The Lp(a)-Lowering Drug Race

RNAi Therapeutics, 06 Feb 2025

Cardiovascular disease (CVD) remains a leading cause of death and morbidity worldwide. According to the WHO, 18 million of the…

Vaxxinity’s cholesterol vaccine reduces LDL in primates

Longevity Technology, 16 Feb 2024

Promising preclinical results for cholesterol vaccine candidate boost hopes for treatment and prevention of heart disease. …

Escepticemia por Gonzalo Casino | Restaurar ensayos

IntraMed, 24 Mar 2023

Sobre la visibilización y el reanálisis de los datos de la investigación clínica

Top 10 most read in January: mortality data in the FOURIER trial and BMI links to frailty

BMJ Open, 09 Feb 2023

Image by Gordon Johnson from…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 24 additional blog posts.